Korean J Pathol.
2008 Feb;42(1):27-32.
DNA Copy Number Changes in Thyroid Medullary Carcinomas Determined by Comparative Genomic Hybridization
- Affiliations
-
- 1Department of Pathology, Inje University Sanggye Paik Hospital, Seoul, Korea.
- 2Department of Medical Genetics, Haartman Institute and Helsinki University Central Hospital, Helsinki, Finland.
- 3Department of Endocrinology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
- 4Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
- 5Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. gygong@amc.seoul.kr
Abstract
- BACKGROUND: A point mutation in the RET proto-oncogene, in medullary thyroid carcinoma (MTC) is well known, but no other genetic causes of MTC have been found. This study was performed to identify the most common DNA copy number changes in MTC by comparative genomic hybridization (CGH). METHODS: Twenty-nine surgically resected MTC specimens were retrospectively selected from patients operated on between 1996 and 2004 at the Asan Medical Center. A review of the clinical data and pathological findings was performed. Congored staining and immunohistochemical stains (calcitonin, chromogranin A and CEA) were processed by tissue microarray. CGH analysis was performed. RESULTS: The Congo-red stain was positive in only 12 cases. The immunohistochemical results were positive in 29 cases for chromogranin A, 26 cases for CEA and 25 cases for calcitonin. DNA copy number changes were found in 23 cases (79.3%). The most frequent change was a gain of 19q (65.5%); less frequent changes were gain of 22 (55.2%), 19p (51.7%), 16p (27.58%), 17q (17.24%), and loss of 4q (27.6%) and 3p (17.24%). CONCLUSIONS: DNA copy number changes of MTC were more common (79.3%) than reported in previous studies. The most frequent changes were gains in 19q, 22 and 19p.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Array-based Comparative Genomic Hybridization and Its Application to Cancer Genomes and Human Genetics
- RAN-aCGH: R GUI Tools for Analysis and Visualization of an Array-CGH Experiment
- Next generation sequencing and array-based comparative genomic hybridization for molecular diagnosis of pediatric endocrine disorders
- Chromosomal gains and losses in primary ovarian carcinomas by comparative genomic hybridization
- Chromosomal Analysis of Anaplastic Thyroid Carcinomas by Comparative Genomic Hybridization
